Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); FDA Panel Supports HIV-OTC
Tweet
Share
E-mailGet Alerts OSUR Hot Sheet
Price: $3.74 --0%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR following a unanimous positive recommendation from the FDA BPAC (Blood Products Advisory Committee)...Unanimous decision could pave way for first infectious disease test approval for home use. BPAC voted 17-0, implying that the benefits outweigh the risks for a home HIV test, while being safe/effective."
"What’s next? Following a spring advisory panel that was also unanimous, we
would now expect the FDA to approve the OraQuick In-Home HIV test by Q3/12, followed by some labelling finalization. Our model assumes the test will add an incremental $7.0M of revenue in its first year (2013)."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $9.10 yesterday.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR following a unanimous positive recommendation from the FDA BPAC (Blood Products Advisory Committee)...Unanimous decision could pave way for first infectious disease test approval for home use. BPAC voted 17-0, implying that the benefits outweigh the risks for a home HIV test, while being safe/effective."
"What’s next? Following a spring advisory panel that was also unanimous, we
would now expect the FDA to approve the OraQuick In-Home HIV test by Q3/12, followed by some labelling finalization. Our model assumes the test will add an incremental $7.0M of revenue in its first year (2013)."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $9.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
- JPMorgan Upgrades TIC Solutions (TIC) to Neutral
- Kepler Cheuvreux Downgrades Avantium N.V (AVTX:NA) to Reduce
Create E-mail Alert Related Categories
Analyst Comments, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
